DSN
GILD icon

D. Scott Neal’s Gilead Sciences GILD Stock Holding History

D. Scott Neal’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-566
Closed -$43K – 104
2018
Q1 		$43K Hold
566
– – 0.02% 85
2017
Q4 		$41K Hold
566
– – 0.02% 85
2017
Q3 		$46K Hold
566
– – 0.03% 82
2017
Q2 		$40K Sell
566
-100
-15% -$6.65K 0.03% 103
2017
Q1 		$45K Sell
666
-150
-18% -$10.5K 0.03% 85
2016
Q4 		$58K Hold
816
– – 0.04% 73
2016
Q3 		$65K Hold
816
– – 0.05% 67
2016
Q2 		$68K Hold
816
– – 0.06% 62
2016
Q1 		$75K Sell
816
-300
-27% -$27.1K 0.07% 51
2015
Q4 		$113K Buy
+1,116
New +$116K 0.09% 42

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D. Scott Neal's GILD Position: Q2 2018 in Review

D. Scott Neal sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 566 shares — an estimated $43K sold.

D. Scott Neal first reported a position in GILD in Q4 2015 and held it in 10 quarters. The position peaked at $113K in Q4 2015. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • D. Scott Neal reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • D. Scott Neal sold 566 Gilead Sciences shares in Q2 2018, an estimated $43K.
  • D. Scott Neal first reported a position in Gilead Sciences in Q4 2015 and held it in 10 quarters.
  • D. Scott Neal's Gilead Sciences position peaked at $113K in Q4 2015.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on D. Scott Neal's 13F filing for Q2 2018, filed 15 Aug 2018.